SEC Form 4 · accession 0001179110-19-000223
IDERA PHARMACEUTICALS, INC. · IDRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Howard H Pien
Director
Period of report
Jan 2, 2019
Accepted (ET)
Jan 3, 2019 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000861838
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 2, 2019 | A | 2,929 | $3.52 | A | 2,929 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This stock was issued to the reporting person pursuant to his election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees.